HK1048050B - 促進肌肉代謝的藥物組份 - Google Patents

促進肌肉代謝的藥物組份

Info

Publication number
HK1048050B
HK1048050B HK03100252.0A HK03100252A HK1048050B HK 1048050 B HK1048050 B HK 1048050B HK 03100252 A HK03100252 A HK 03100252A HK 1048050 B HK1048050 B HK 1048050B
Authority
HK
Hong Kong
Prior art keywords
anabolic
pharmaceutical composition
anabolism
initiators
denatured
Prior art date
Application number
HK03100252.0A
Other languages
English (en)
Other versions
HK1048050A1 (en
Inventor
Rudolf Leonardus Lodewijk Smeets
Robert Johan Joseph Hageman
Original Assignee
Nv Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23990994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1048050(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nv Nutricia filed Critical Nv Nutricia
Publication of HK1048050A1 publication Critical patent/HK1048050A1/xx
Publication of HK1048050B publication Critical patent/HK1048050B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03100252.0A 2000-02-10 2003-01-10 促進肌肉代謝的藥物組份 HK1048050B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/500,802 US6521591B1 (en) 2000-02-10 2000-02-10 Pharmaceutical composition for muscular anabolism
PCT/NL2001/000112 WO2001058284A1 (en) 2000-02-10 2001-02-12 Pharmaceutical composition for muscular anabolism

Publications (2)

Publication Number Publication Date
HK1048050A1 HK1048050A1 (en) 2003-03-21
HK1048050B true HK1048050B (zh) 2009-12-31

Family

ID=23990994

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100252.0A HK1048050B (zh) 2000-02-10 2003-01-10 促進肌肉代謝的藥物組份

Country Status (9)

Country Link
US (1) US6521591B1 (zh)
EP (1) EP1253830B1 (zh)
AT (1) ATE447858T1 (zh)
AU (2) AU2001237809B2 (zh)
CA (1) CA2398990C (zh)
DE (1) DE60140426D1 (zh)
ES (1) ES2336764T3 (zh)
HK (1) HK1048050B (zh)
WO (1) WO2001058284A1 (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20050143343A1 (en) * 2003-12-30 2005-06-30 Nerenberg Arnold P. Nutritional supplement for enhancing the production and effect of natural human growth hormone
US7799817B2 (en) * 2004-02-20 2010-09-21 Lifescape Biosciences Inc Compositions and methods for sleep regulation
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20060013889A1 (en) * 2004-07-16 2006-01-19 Playford Raymond J Colostrum-based treatment for irritable bowel syndrome
CN101048179A (zh) * 2004-08-25 2007-10-03 Mtor配方设计公司 在骨骼肌中活化蛋白合成以及使分解代谢过程减活的组合物和方法
US7426440B2 (en) * 2004-09-24 2008-09-16 Nutritional Bioscience Ltd. Repair and protection factor scoring method for bioactive agents
US20060068022A1 (en) * 2004-09-29 2006-03-30 Playford Raymond J Bioactive agent compositions for repair of cell injuries
CA2537647A1 (en) * 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
DE102005028446A1 (de) * 2005-06-17 2006-12-28 Sibylle E. Bauer Zusammensetzung, insbesondere Nahrungsergänzungsmittel
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
CN102225060A (zh) 2005-12-19 2011-10-26 雅培制药有限公司 β-羟基-β-甲基丁酸盐在调节1-型和2-型细胞因子生成失衡中的应用
CN101524155B (zh) * 2009-04-20 2012-10-10 北京康比特体育科技股份有限公司 一种氨基酸组合物
MX2012008786A (es) * 2010-01-29 2012-08-17 Abbott Lab Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbut irato (hmb) de calcio y proteina soluble.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
PE20121729A1 (es) 2010-01-29 2013-01-16 Abbott Lab Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb) de calcio
RU2012125879A (ru) * 2010-01-29 2014-03-10 Эбботт Лэборетриз Питательные порошки, содержащие высушенный распылением бета-гидрокси-бета-метилбутират (гмб)
US8916217B2 (en) 2010-01-29 2014-12-23 Abbott Laboratories Aseptically packaged nutritional liquids comprising HMB
CN101791127B (zh) * 2010-03-05 2012-07-18 北京康比特体育科技股份有限公司 一种含有HMβ的肌肉保护组合物
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
EP2926669B1 (de) 2014-04-02 2017-05-24 AlzChem AG Kreatin-Proteinmatrix sowie Verfahren zur Herstellung dieser Matrix
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
TWI737987B (zh) * 2019-04-23 2021-09-01 豐華生物科技股份有限公司 一種乳酸菌菌株在製備提升運動能力與抗疲勞之組合物之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347890B1 (en) * 1988-06-22 1993-03-17 Roussel Morishita Co., Ltd. Amino acid nutrient compositions
US5726146A (en) * 1994-12-06 1998-03-10 Natural Supplement Association, Incorporated Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
WO1998043617A2 (en) 1997-03-27 1998-10-08 Sole Michael J Nutritional composition for improvements in cell energetics
EP0875155A1 (en) 1997-05-01 1998-11-04 N.V. Nutricia Peri-operative drink
AUPP327198A0 (en) * 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
DE69930746T2 (de) 1998-06-10 2007-03-15 Crum, Albert B. Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems

Also Published As

Publication number Publication date
AU3780901A (en) 2001-08-20
DE60140426D1 (de) 2009-12-24
WO2001058284A1 (en) 2001-08-16
EP1253830A1 (en) 2002-11-06
HK1048050A1 (en) 2003-03-21
CA2398990C (en) 2013-04-02
CA2398990A1 (en) 2001-08-16
AU2001237809B2 (en) 2005-04-07
ES2336764T3 (es) 2010-04-16
US6521591B1 (en) 2003-02-18
EP1253830B1 (en) 2009-11-11
ATE447858T1 (de) 2009-11-15

Similar Documents

Publication Publication Date Title
AU3780901A (en) Pharmaceutical composition for muscular anabolism
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NZ515902A (en) Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, and type 2 diabetes
NZ527123A (en) Oxazolyl-pyrazole derivatives as kinase inhibitors
WO2002048183A3 (en) Compositions of peptide crystals
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
IL139227A0 (en) N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders
MXPA02011303A (es) Nueva composicion farmaceutica.
BG106251A (en) Levodopa (carbidopa) entacapone pharmaceutical preparation
AU2003301959A1 (en) Substituted cycloalkyl p1' hepatitis c virus inhibitors
AU5242000A (en) Nematicidal trifluorobutenes
AU7031500A (en) Therapeutic quinazoline compounds
DE50015623D1 (de) Kovalent verbrückte insulindimere
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP0932613A4 (en) EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS
AU2003304180A1 (en) Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
GB9907571D0 (en) Compounds
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
WO2003059262A3 (en) Method and composition for treating and preventing hiv infection and aids
WO2003099849A3 (en) Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20210211